Cic edizioni internazionali
Functional Neurology

Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey

Original Article, 253 - 258
doi: 10.11138/FNeur/2013.28.4.253
Tag this article
Abstract
Enhanced HTML Full text PDF
The aim of this survey was to provide an overview of important issues relating to therapeutic strategies based on botulinum toxin type A injection for the treatment of patients with neurological disorders.
Two hundred and ten physicians from neurology and neurorehabilitation units in Italian hospitals answered a questionnaire exploring some clinical aspects of the use of botulinum toxin type A in patients with spasticity/dystonia. 66% of the physicians treated patients with dystonia, 80% treated adults with spasticity, and 35% treated children with cerebral palsy.
Palpation with no instrumental guidance was the injection technique most commonly used for treating patients with dystonia, spasticity and cerebral palsy; 57% of the physicians evaluated patients instrumentally before toxin injection, while 45% assessed postinjection improvements by instrumental means; 78% of the physicians prescribed (when appropriate) rehabilitation procedures after toxin injection. Our results seem to show that the routine use of botulinum toxin in clinics is far from standardized.

Vol. XXXIV (No. 1) 2019 January - March

  1. Robots for stroke rehabilitation: not all that glitters is gold
    Morone G.
  2. Visual-spatial training in patients with sub-acute stroke without neglect: a randomized, single-blind controlled trial
    Tramontano M., Dell'Uomo D., Cinnera A.M., Luciani C., Di Lorenzo C., Marcotulli M., Vona F., Mercuro A., Abbruzzese S.
  3. Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer’s disease
    Chiaravalloti A., Fuccillo E., Martorana A., Ricci M., Giacomini P.G., Schillaci O., Di Girolamo S.
  4. The role of Personal KinetiGraph™ fluctuator score in quantifying the progression of motor fluctuations in Parkinson’s disease
    Tan E.E., Hogg E.J., Tagliati M.
  5. Evaluation of the psychometric properties of the Barthel Index in an Italian ischemic stroke population in the acute phase: a cross-sectional study
    Galeoto G., Formica M.C., Mercuri N.B., Santilli V., Berardi A. C., Castiglia S.F., Mollica R., Servadio A.
  6. Augmentative and alternative communication improves quality of life in the early stages of amyotrophic lateral sclerosis
    Maresca G., Pranio F., Naro A., De Luca R., Maggio M.G., Scarcella I., De Domenico C., Bramanti P., Conti Nibali V., Portaro S., Calabrò R.S.
  7. Effectiveness of intensive neurorehabilitation in obese subacute stroke patients
    Ciancarelli I., Tonin P., Garo M.L., Tozzi Ciancarelli M.G.
  8. A novel neurocognitive rehabilitation tool in the recovery of hemiplegic hand grip after stroke: a case report
    Paolucci T., Capobianco S.V., Vinciguerra S.M., Cilli M., Villani C., Saraceni V.M.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey
    Smania N., Colosimo C., Bentivoglio A.R., Sandrini G., Picelli A.
    doi: 10.11138/FNeur/2013.28.4.253
credits